Urinary tract infections vaccine - XanodyneAlternative Names: UTI vaccine - Xanodyne
Latest Information Update: 24 Aug 2015
At a glance
- Originator Xanodyne Pharmaceuticals
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Urinary tract infections
Most Recent Events
- 24 Aug 2015 Discontinued - Phase-II for Urinary tract infections in USA (Transmucosal)
- 15 Dec 2004 Phase-II clinical trials in Urinary tract infections in USA (Transmucosal)